TCF4 silencing sensitizes the colon cancer cell line to oxaliplatin as a common chemotherapeutic drug
- PMID: 24869759
- DOI: 10.1097/CAD.0000000000000118
TCF4 silencing sensitizes the colon cancer cell line to oxaliplatin as a common chemotherapeutic drug
Abstract
Colon cancer is among the most prevalent cancers worldwide. Although the main modality of treatment is surgery, resistance to chemoradiotherapy raises concerns. Hence, we aimed to determine the effect of RNA-mediated silencing of tcf4, the downstream effector of the wnt signaling pathway, on the response of the SW480 cell line to oxaliplatin, a common chemotherapeutic drug. For this, two different silencing sequences against TCF4 mRNA were selected and cloned into pSilencer neo2.1. The SW480 cell line was stably transfected with the silencing constructs (namely p1396, p1874, and p silencer containing a scrambled sequence) and labeled SW1396, SW1874, and SW-Sc, respectively. Subsequently, the effect of oxaliplatin (from 0 to 11.25 μmol/l) on these cells was studied using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide proliferation assay. Suppression of tcf4 expression in stable transfected cells with p1396 and p1874 was confirmed by quantitative reverse transcription-PCR and western blot analysis. Although oxaliplatin was not toxic to SW480 and SW-sc in the range tested, in SW1396 and SW1874 cells, a toxic effect was evident at 3.75 and 4.375 μmol/l. Also, SW1396 and SW1874 cells appeared to have a round shape in comparison with SW480 and SW-Sc cells. Only for SW1396, the number of apoptotic cells was significantly different before and after the addition of oxaliplatin (LC50 of oxaliplatin). The proliferating cells in SW480, SW1874, and SW-Sc increased after treatment with oxaliplatin; however, this was not observed in SW1396. Although silencing the tcf4 gene would confer sensitivity to oxaliplatin in SW1874 and especially SW1396, in SW480 and SW-Sc, the lethal effect of oxaliplatin was compensated by its effect in increasing the proliferation of cells. This sensitization effect may be because of different mechanisms including TCF4 motifs in the ABCB1 promoter or defects in nucleotide excision repair or double-strand break repair systems after tcf4 silencing.
Similar articles
-
siRNA-mediated silencing of MDR1 reverses the resistance to oxaliplatin in SW480/OxR colon cancer cells.Cell Mol Biol (Noisy-le-grand). 2015 May 28;61(2):98-103. Cell Mol Biol (Noisy-le-grand). 2015. PMID: 26025411
-
Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy.Carcinogenesis. 2011 Dec;32(12):1824-31. doi: 10.1093/carcin/bgr222. Epub 2011 Oct 8. Carcinogenesis. 2011. PMID: 21983179 Free PMC article.
-
Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.Cancer Invest. 2009 Jul;27(6):604-12. doi: 10.1080/07357900802337191. Cancer Invest. 2009. PMID: 19440933
-
Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.Jpn J Clin Oncol. 2005 Aug;35(8):453-63. doi: 10.1093/jjco/hyi130. Epub 2005 Jul 15. Jpn J Clin Oncol. 2005. PMID: 16024531
-
SW480 colorectal cancer cells that naturally express Lgr5 are more sensitive to the most common chemotherapeutic agents than Lgr5-negative SW480 cells.Anticancer Drugs. 2015 Oct;26(9):942-7. doi: 10.1097/CAD.0000000000000270. Anticancer Drugs. 2015. PMID: 26196680
Cited by
-
Exosome-derived microRNAs contribute to prostate cancer chemoresistance.Int J Oncol. 2016 Aug;49(2):838-46. doi: 10.3892/ijo.2016.3560. Epub 2016 Jun 3. Int J Oncol. 2016. PMID: 27278879 Free PMC article.
-
Epithelial-Mesenchymal Transition and Breast Cancer.J Clin Med. 2016 Jan 26;5(2):13. doi: 10.3390/jcm5020013. J Clin Med. 2016. PMID: 26821054 Free PMC article. Review.
-
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers.Cancers (Basel). 2021 May 27;13(11):2638. doi: 10.3390/cancers13112638. Cancers (Basel). 2021. PMID: 34072037 Free PMC article. Review.
-
A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells.Breast Cancer Res Treat. 2017 Jun;163(3):449-460. doi: 10.1007/s10549-017-4211-y. Epub 2017 Mar 23. Breast Cancer Res Treat. 2017. Retraction in: Breast Cancer Res Treat. 2024 Jul;206(1):213. doi: 10.1007/s10549-024-07371-1. PMID: 28337662 Free PMC article. Retracted.
-
Precise and efficient siRNA design: a key point in competent gene silencing.Cancer Gene Ther. 2016 Apr;23(4):73-82. doi: 10.1038/cgt.2016.4. Epub 2016 Mar 18. Cancer Gene Ther. 2016. PMID: 26987292 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources